Charles Zarnitsky

2.2k total citations
19 papers, 463 citations indexed

About

Charles Zarnitsky is a scholar working on Rheumatology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Charles Zarnitsky has authored 19 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rheumatology, 7 papers in Surgery and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Charles Zarnitsky's work include Rheumatoid Arthritis Research and Therapies (4 papers), Autoimmune Bullous Skin Diseases (3 papers) and Systemic Lupus Erythematosus Research (3 papers). Charles Zarnitsky is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (4 papers), Autoimmune Bullous Skin Diseases (3 papers) and Systemic Lupus Erythematosus Research (3 papers). Charles Zarnitsky collaborates with scholars based in France, Canada and Portugal. Charles Zarnitsky's co-authors include Vincent Goëb, Jacques‐Olivier Pers, Xavier Mariette, Xavier Puéchal, Jean‐Jacques Dubost, Jacques Morel, Aleth Perdriger, Sandrine Jousse‐Joulin, Alain Saraux and Jean Sibilia and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Internal Medicine.

In The Last Decade

Charles Zarnitsky

16 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles Zarnitsky France 8 235 190 151 75 72 19 463
M. Maset Italy 7 357 1.5× 185 1.0× 193 1.3× 58 0.8× 35 0.5× 12 495
Guillermo Carvajal Alegria France 11 133 0.6× 174 0.9× 85 0.6× 20 0.3× 37 0.5× 41 373
R. La Corte Italy 12 65 0.3× 214 1.1× 68 0.5× 21 0.3× 58 0.8× 22 478
Sara S. McCoy United States 13 233 1.0× 194 1.0× 80 0.5× 50 0.7× 69 1.0× 38 519
J Brun Norway 11 272 1.2× 102 0.5× 116 0.8× 38 0.5× 45 0.6× 19 409
Alison M Boyce United States 11 56 0.2× 236 1.2× 74 0.5× 154 2.1× 71 1.0× 23 432
Yi Dong China 9 232 1.0× 167 0.9× 107 0.7× 26 0.3× 34 0.5× 33 430
Frédéric Desmoulins France 5 262 1.1× 127 0.7× 108 0.7× 59 0.8× 20 0.3× 6 342
Αριστέα Παπαγεωργίου Greece 8 381 1.6× 89 0.5× 250 1.7× 65 0.9× 49 0.7× 13 505
S. Dass United Kingdom 4 202 0.9× 182 1.0× 101 0.7× 47 0.6× 5 0.1× 8 386

Countries citing papers authored by Charles Zarnitsky

Since Specialization
Citations

This map shows the geographic impact of Charles Zarnitsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Zarnitsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Zarnitsky more than expected).

Fields of papers citing papers by Charles Zarnitsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Zarnitsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Zarnitsky. The network helps show where Charles Zarnitsky may publish in the future.

Co-authorship network of co-authors of Charles Zarnitsky

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Zarnitsky. A scholar is included among the top collaborators of Charles Zarnitsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Zarnitsky. Charles Zarnitsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Hulin, Cyrille, Aurore Perrot, Margaret Macro, et al.. (2022). Retreatment of Patients with Anti CD38-Based Combinations in Multiple Myeloma in Real-Life: Results from the Emmy Cohort Study. Blood. 140(Supplement 1). 7133–7135. 3 indexed citations
2.
Curie, Aurore, et al.. (2021). Vascularites à ANCA précédées d’une atteinte articulaire isolée. À propos de deux cas et revue de la littérature. La Revue de Médecine Interne. 42(9). 650–653.
3.
Zarnitsky, Charles, et al.. (2020). Microbiological diagnosis of suspected vertebral osteomyelitis with a focus on the yield of percutaneous needle biopsy: a 10-year cohort study. European Journal of Clinical Microbiology & Infectious Diseases. 40(2). 297–302. 7 indexed citations
4.
Zarnitsky, Charles, et al.. (2019). Syndrome de Sweet médicamenteux à l’hydroxychloroquine : à propos de 2 cas. La Revue de Médecine Interne. 41(4). 289–292. 4 indexed citations
5.
Zarnitsky, Charles, et al.. (2019). Effet indésirable rare d’un anti-IL-1RA. La Revue de Médecine Interne. 41(5). 343–345.
6.
Zarnitsky, Charles, et al.. (2018). Syndrome de Sweet médicamenteux à l’hydroxychloroquine : à propos de 2 cas. La Revue de Médecine Interne. 39. A171–A172. 1 indexed citations
7.
Litrowski, N., C. Boulard, Florent Marguet, et al.. (2017). Necrotizing autoimmune myopathy associated with POEMS syndrome report. QJM. 111(1). 49–50. 3 indexed citations
8.
Devauchelle‐Pensec, Valérie, Xavier Mariette, Sandrine Jousse‐Joulin, et al.. (2014). Treatment of Primary Sjögren Syndrome With Rituximab. Annals of Internal Medicine. 160(4). 233–242. 267 indexed citations
9.
10.
Delforge, Michel, Leonard Minuk, Jean‐Claude Eisenmann, et al.. (2014). Health-related quality of life (HRQOL) in transplant-ineligible patients (pts) with newly diagnosed multiple myeloma (NDMM): Results from the first trial.. Journal of Clinical Oncology. 32(15_suppl). 8516–8516. 3 indexed citations
11.
Zarnitsky, Charles, A Daragon, Jean‐Nicolas Dacher, et al.. (2012). Efficacy of anti-TNF in patients with spondyloarthritis in absence of any imaging sign. Joint Bone Spine. 80(3). 280–286. 9 indexed citations
12.
Trouvin, Anne‐Priscille, et al.. (2012). Analgesic effect of sacroplasty in osteoporotic sacral fractures: A study of six cases. Joint Bone Spine. 79(5). 500–503. 21 indexed citations
13.
Devauchelle‐Pensec, Valérie, Xavier Mariette, Sandrine Jousse‐Joulin, et al.. (2012). OP0065 Tolerance and efficacy of rituximab in primary sjogren syndrome (TEARS): Results of a randomized controlled trial. Annals of the Rheumatic Diseases. 71. 75–75. 8 indexed citations
14.
15.
Chopin, Florence, Patrick Garnero, Anne Le Hénanff, et al.. (2007). Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 67(3). 353–357. 103 indexed citations
16.
17.
Zarnitsky, Charles, et al.. (1997). Thromboangiitis obliterans with arthralgia, diarrhea and nodules as the first symptoms.. PubMed. 64(5). 353–4. 1 indexed citations
18.
Zarnitsky, Charles, et al.. (1989). Ostéomyélite chronique brucellienne de l'humérus.. 56(4). 1 indexed citations
19.
Zarnitsky, Charles, et al.. (1988). [Association of Hirschsprung disease, Meckel's diverticulum and gallbladder calculi in a young Down's syndrome patient].. PubMed. 24(1). 21–2. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Maset Breakdown of academic impact, for papers by Guillermo Carvajal Alegria Breakdown of academic impact, for papers by R. La Corte Breakdown of academic impact, for papers by Sara S. McCoy Breakdown of academic impact, for papers by J Brun Breakdown of academic impact, for papers by Alison M Boyce Breakdown of academic impact, for papers by Yi Dong Breakdown of academic impact, for papers by Frédéric Desmoulins Breakdown of academic impact, for papers by Αριστέα Παπαγεωργίου Breakdown of academic impact, for papers by S. Dass
Rankless by CCL
2026